Last news
Global Times: Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era receives high recognition from intl community: 2025 Global Survey on Impression and Understanding of China

Global Times: Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era receives high recognition from intl community: 2025 Global Survey on Impression and Understanding of China

BEIJING, Dec. 29, 2025 /PRNewswire/ -- In 2025, the world is undergoing accelerated transformation amid rising turbulence and uncertainty. The interconnectedness between China's development and the global landscape continues to grow, with China...

ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange

ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange

Thai investors now can trade in real-time during local market hours using baht without overseas accounts, while also benefiting from capital gains tax exemptions. BEIJING, Dec. 29, 2025 /PRNewswire/ -- Today, China Asset Management Co. (ChinaAMC)...

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech has...

Alphamab Oncology Announces IND Application for a Phase II Clinical Study of HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 as First-line Treatment of Advanced Cervical Cancer was Officially Accepted by CDE

Alphamab Oncology Announces IND Application for a Phase II Clinical Study of HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 as First-line Treatment of Advanced Cervical Cancer was Officially Accepted by CDE

SUZHOU, China, Dec. 29, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2...

JA Solar Ranked No. 1 Global Solar Module Manufacturer by Wood Mackenzie

JA Solar Ranked No. 1 Global Solar Module Manufacturer by Wood Mackenzie

BEIJING, Dec. 29, 2025 /PRNewswire/ -- JA Solar, a trusted global partner in green energy, is ranked No. 1 worldwide in the Wood Mackenzie Global Solar Module Manufacturer Ranking for the first half of 2025, achieving an overall score of 91.7, the...

XPENG-Peking University Collaborative Research Accepted by AAAI 2026: Introducing a Novel Visual Token Pruning Framework for Autonomous Driving

XPENG-Peking University Collaborative Research Accepted by AAAI 2026: Introducing a Novel Visual Token Pruning Framework for Autonomous Driving

XPENG-PKU Research Breakthrough: XPENG, in collaboration with Peking University, has developed FastDriveVLA—a novel visual token pruning framework that enables autonomous driving AI to "drive like a human" by focusing only on essential information,...

JinkoSolar Announces Results of 2025 Annual General Meeting

JinkoSolar Announces Results of 2025 Annual General Meeting

SHANGRAO, China, Dec. 29, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that all shareholders...

CGTN: China's Hottest Winter Party

CGTN: China's Hottest Winter Party

BEIJING, Dec. 29, 2025 /PRNewswire/ -- CGTN's "China's Coldest City, Hottest Party" is a look at the rise in popularity of Dongbei, or China's Northeast, as a top winter destination. It is also the story of a region where snow and ice once felt like...

1 ... 255 256 257 258 259 260 261 262 263 ... 3702
menu
menu